Indian drugmaker Mankind Pharma Ltd on Thursday said it has signed a deal to buy Bharat Serums & Vaccines Ltd (BSV), from private equity firm Advent International for Rs 13,630 crores ($1.63 billion).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
